Overview

The PEERLESS II Study

Status:
Recruiting

Trial end date:
2026-07-01

Target enrollment:

Participant gender:

Summary

This study is a prospective, multicenter, randomized controlled trial of the FlowTriever System plus anticoagulation compared to anticoagulation alone for intermediate-risk acute PE.

Phase:

N/A

Details

Lead Sponsor:

Inari Medical

Treatments:

Anticoagulants